All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY582 | Anti-NIPSNAP2 (1B2) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1B2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY583 | Anti-NIPSNAP2 (1B8) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Dog, Monkey | 1B8 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY585 | Anti-NIPSNAP2 (1D6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1D6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY586 | Anti-NIPSNAP2 (CBLG1-2643) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2643 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY587 | Anti-NIPSNAP2 (CBLG1-2644) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Dog, Rat, Monkey, Mouse | CBLG1-2644 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY588 | Anti-NIPSNAP2 (CBLG1-2645) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2645 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2222 | Anti-NIPSNAP2(1B2) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1B2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2223 | Anti-NIPSNAP2(1B8) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Mouse, Rat, Dog, Monkey | 1B8 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2225 | Anti-NIPSNAP2(1D6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1D6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2226 | Anti-NIPSNAP2(CBLG1-2643) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2643 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2227 | Anti-NIPSNAP2(CBLG1-2644) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Dog, Rat, Monkey, Mouse | CBLG1-2644 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2228 | Anti-NIPSNAP2(CBLG1-2645) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBLG1-2645 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION